Deletions of pfhrp2 and pfhrp3 genes were uncommon in rapid diagnostic test-negative Plasmodium falciparum isolates from Uganda
- PMID: 33386076
- PMCID: PMC7777526
- DOI: 10.1186/s12936-020-03547-4
Deletions of pfhrp2 and pfhrp3 genes were uncommon in rapid diagnostic test-negative Plasmodium falciparum isolates from Uganda
Abstract
Background: Rapid diagnostic tests (RDTs) play a key role in malaria case management. The most widely used RDT identifies Plasmodium falciparum based on immunochromatographic recognition of P. falciparum histidine-rich protein 2 (PfHRP2). Deletion of the paralogous pfhrp2 and pfhrp3 genes leads to false-negative PfHRP2-based RDTs, and has been reported in P. falciparum infections from South America and Africa. However, identification of pfhrp2/pfhrp3 deletions has usually been based only on failure to amplify these genes using PCR, without confirmation based on PfHRP2 protein expression, and understanding of the true prevalence of deletions is incomplete.
Methods: Deletions of pfhrp2/pfhrp3 in blood samples were investigated from cross-sectional surveys in 2012-13 in three regions of varied malaria transmission intensity in Uganda. Samples with positive Giemsa-stained thick blood smears, but negative PfHRP2-based RDTs were evaluated by PCR amplification of conserved subunit ribosomal DNA for Plasmodium species, PCR amplification of pfhrp2 and pfhrp3 genes to identify deletions, and bead-based immunoassays for expression of PfHRP2.
Results: Of 3516 samples collected in cross-sectional surveys, 1493 (42.5%) had positive blood smears, of which 96 (6.4%) were RDT-negative. Of these 96 RDT-negative samples, P. falciparum DNA was identified by PCR in 56 (58%) and only non-falciparum plasmodial DNA in 40 (42%). In all 56 P. falciparum-positive samples there was a failure to amplify pfhrp2 or pfhrp3: in 25 (45%) pfhrp2 was not amplified, in 39 (70%) pfhrp3 was not amplified, and in 19 (34%) neither gene was amplified. For the 39 P. falciparum-positive, RDT-negative samples available for analysis of protein expression, PfHRP2 was not identified by immunoassay in only four samples (10.3%); these four samples all had failure to amplify both pfhrp2 and pfhrp3 by PCR. Thus, only four of 96 (4.2%) smear-positive, RDT-negative samples had P. falciparum infections with deletion of pfhrp2 and pfhrp3 confirmed by failure to amplify the genes by PCR and lack of expression of PfHRP2 demonstrated by immunoassay.
Conclusion: False negative RDTs were uncommon. Deletions in pfhrp2 and pfhrp3 explained some of these false negatives, but most false negatives were not due to deletion of the pfhrp2 and pfhrp3 genes.
Keywords: HRP2; Plasmodium falciparum; Rapid diagnostic test; pfhrp2; pfhrp3.
Conflict of interest statement
All authors declare that they have no competing interests.
Similar articles
-
Community-based surveys for Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions in selected regions of mainland Tanzania.Malar J. 2020 Nov 4;19(1):391. doi: 10.1186/s12936-020-03459-3. Malar J. 2020. PMID: 33148255 Free PMC article.
-
Histidine-rich protein (hrp) 2-based RDT false-negatives and Plasmodium falciparum hrp 2 and 3 gene deletions in low, seasonal and intense perennial transmission zones in Cameroon: a cross - sectional study.BMC Infect Dis. 2024 Sep 30;24(1):1080. doi: 10.1186/s12879-024-09935-4. BMC Infect Dis. 2024. PMID: 39350071 Free PMC article.
-
Molecular surveillance of pfhrp2 and pfhrp3 genes deletion in Plasmodium falciparum isolates and the implications for rapid diagnostic tests in Nigeria.Acta Trop. 2019 Aug;196:121-125. doi: 10.1016/j.actatropica.2019.05.016. Epub 2019 May 16. Acta Trop. 2019. PMID: 31103699
-
Impact of Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions on malaria control worldwide: a systematic review and meta-analysis.Malar J. 2021 Jun 22;20(1):276. doi: 10.1186/s12936-021-03812-0. Malar J. 2021. PMID: 34158065 Free PMC article.
-
Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: a threat to diagnosis of P. falciparum malaria.Clin Microbiol Infect. 2019 May;25(5):580-585. doi: 10.1016/j.cmi.2018.09.009. Epub 2018 Sep 27. Clin Microbiol Infect. 2019. PMID: 30267926 Review.
Cited by
-
Field evaluation of the Bioline Malaria Ag P.f/Pan rapid diagnostic test: causes of microscopy discordance and performance in Uganda.Malar J. 2025 May 1;24(1):138. doi: 10.1186/s12936-025-05379-6. Malar J. 2025. PMID: 40312382 Free PMC article.
-
Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africa.Front Cell Infect Microbiol. 2022 Jul 13;12:757844. doi: 10.3389/fcimb.2022.757844. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35909968 Free PMC article. Review.
-
Deletion patterns, genetic variability and protein structure of pfhrp2 and pfhrp3: implications for malaria rapid diagnostic test in Amhara region, Ethiopia.Malar J. 2022 Oct 8;21(1):287. doi: 10.1186/s12936-022-04306-3. Malar J. 2022. PMID: 36209103 Free PMC article.
-
Field evaluation of the Bioline Malaria Ag P.f/Pan Rapid Diagnostic Test: Causes of Microscopy Discordance and Performance in Uganda.Res Sq [Preprint]. 2025 Feb 19:rs.3.rs-5629938. doi: 10.21203/rs.3.rs-5629938/v1. Res Sq. 2025. Update in: Malar J. 2025 May 1;24(1):138. doi: 10.1186/s12936-025-05379-6. PMID: 40034450 Free PMC article. Updated. Preprint.
-
Factors Affecting the Performance of HRP2-Based Malaria Rapid Diagnostic Tests.Trop Med Infect Dis. 2022 Sep 25;7(10):265. doi: 10.3390/tropicalmed7100265. Trop Med Infect Dis. 2022. PMID: 36288006 Free PMC article. Review.
References
-
- WHO. World malaria report. Geneva, Global Malaria Programme, World Health Organization, 2019:232.
-
- Lee N, Baker J, Andrews KT, Gatton ML, Bell D, Cheng Q, et al. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: implications for rapid diagnostic tests for malaria. J Clin Microbiol. 2006;44:2773–2778. doi: 10.1128/JCM.02557-05. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources